Vaidya Sane Ayurved Laboratories Limited — Updates, 28-11-2025: General Updates
28-11-2025 | 04:06 pm
28-11-2025 | 04:06 pm
Madhavbaug's preferential issue size revised from ₹0.56 Cr to ₹0.40 Cr. However, funds totaling ₹73.20 Cr from warrant conversion are earmarked for working capital (₹15 Cr), general corporate needs (₹13.20 Cr), and CAPEX (₹45 Cr). A monitoring agency will track fund usage.
No comments yet. Be the first to comment!
All announcements from Vaidya Sane Ayurved Laboratories Limited
